Johnson & Johnson

Subscribe to Johnson & Johnson

Today, major healthcare companies are investing heavily into various AI-powered devices. For example, Zimmer Biomet and the New York City-based Hospital for Special Surgery recently inked a three-year deal to create the HSS/Zimmer Biomet Innovation Center for Artificial Intelligence in Robotic Joint Replacement. “The collaboration aims to develop decision support tools—powered by data collection and machine learning — to assist surgeons planning and predicting outcomes for robotic-assisted joint replacements.” Additionally, Johnson & Johnson have gone on record saying that they see “a huge opportunity to harness data, machine learning and artificial intelligence to help drive decision-making at all levels of healthcare.” As artificial intelligence starts playing a larger role in the modern healthcare space, a critical question will need to be answered: Are AI-powered solutions products or services?
Continue Reading Is Your Artificial Intelligence a Service or a Product?

Varun Saxena from Fierce Medical Devices recently reported that partners Johnson & Johnson and Google are designing their own robotic surgery devices, which “will compete with Intuitive in general surgery arenas, which include hernia repair and colorectal surgery.”  The Johnson & Johnson endeavor was formed in collaboration with Google’s Verily Life Sciences and will operate under the name Verb Surgical Inc.. 
Continue Reading As New Players Enter the Robotic Surgery Field, the Legal Implications are Limitless